HomeAbout SPIFor PatientsFor PhysiciansSPI DoctorsDirections206.215.2480

Clinical Training CoursesTechnical AssistanceBrachytherapy ConferencePCa Commentary



PCa Commentary
 

Multi-focal Prostate Cancer (April 2003)

The consensus from pathological studies is that PC most times presents as multiple sites within the prostate. This has implications relating to biopsy strategy, and, at a fundamental level, has potential for understanding the genesis of the disease. Studies of glands removed for incidental reasons (such as with a cystectomy) or in the treatment of known prostate cancer find multiple sites of disease in 50% - 76% of specimens. In a study conducted at Stanford and reported by Wise (joined also by Stamey and McNeal: UROLOGY 60;(2)2002,p 264) only 17% of 486 glands had a single foci, 16% had two, and the remaining had from 3 to 12 independent sites. Another study (Miller GJ, J UROL 1994; Nov) reported solitary lesions in 43% of 151 glands, two lesions in 31.1%, and the remaining 25.2% containing 2 to 6 tumors. Djavan in 1999 found multifocality in 66.9% of 308 specimens, with 63% having two lesions, and 37% three or more.

What else do these studies reveal?l) The Wise study found that when multifocality exists the size of the largest tumor decreases as the number of additional sites increases. After contemplating this relationship the authors were led to consider whether tumors might enlarge by accretion, "swallowing up" the surrounding smaller tumor sites, particularly in the small confines of the peripheral zones. The secondary tumors were mostly small, >.5 cm3 in 58% of the observations. (Another study found 80% of the secondary lesions < .5 cm3). Wise's follow-up results indicated that the risk of biochemical relapse, however, was related to the size and grade of the largest tumor. Their follow-up results led them to speculate that multiplicity was in some way protective since patients with multifocal disease had better outcomes than patients with solitary lesions when those patients' largest tumors were of similar size.2) The Miller study found "that tumors need not acquired either large volume or high grade before they" invade through the prostatic capsule. Among capsule invading tumors of less than 3 cm3 there was an equal division between those with Gleason sums of 2,3, and 4 and those of 5,6, and 7. Contrary to Wise (above) Miller's opinion was that multifocality adversely affected prognosis. 70% of the organ confined tumors less than 1 cm3 had a Gleason sum of 4 or less.

Several thoughts arise from the fact of frequent multifocality. Considering the relatively small size of a biopsy specimen, sampling error is lessened by more probes into a potentially multifocal tumor field. Currently there is a worthwhile effort to try to relate the risk of treatment failure to the "number of positive biopsy cores", but the randomness of hitting or missing additional tumor sites will challenge the statistical strength of this association. (Dr. Kattan is currently attempting to include this factor in the Partin Tables). A study by Mazal (Eur Urol, 2001, June) addressed the issue of spacial distribution of multiple prostate cancers. Prostatectomy specimens from men whose initial biopsies were negative revealed biopsy-undetected tumor most frequently in the apical region (p<0.001) and the the dorsal region (p<0.01).

Ruijter (J Pathol 1996 Nov, and 1999 July) probed the issue of multifocality deeper by studying the histological relationship among a prostate's various tumors. In the 1996 study whole mount prostatectomy specimens for 61 T2 prostate cancers were mapped for histological grade heterogeneity and tumor multifocality. Multiple tumors occurred in 72% and only 16% showed a single histologic grade. Extracapsular invasion was often associated with tumors of small volume and low histological grade. Variability of histological grade was directly proportional to the total tumor volume. The 1999 study attempted to further the analysis by using sophisticated molecular biological techniques to examine for clonal concordance among tumors. This proved to be a very challenging effort. Some individual tumors contained several distinct clones, and among tumors in a single prostate specimen the various tumor sites often showed a mixture of clonal similarity and difference. Their conclusion was that "no clear evidence was obtained for either a clonal or a non-clonal origin of multiple lesions in a given prostate".

Since there is strong support for the hypotheses that high-grade prostatic intraepithelial neoplasia (HGPIN) is a precursor to cancer, it's possible that the study of this lesion may provide clues to the "first three minutes" of the genesis of small emerging galaxies of early cancer in the multi-billion cell universe of the prostate gland. Bostwick, by studying chromosome regularity (karyometry) among the nuclei of a single HGPIN lesion found evidence that even at this stage there were differences in chromosome numbers. A Spanish researcher compared chromosome features between HGPIN and PC in a single prostate and found that in 75% the two lesions shared abnormalities of chromosome 7 and 8, common know abnormalities. And to make the analysis even more complicated an Italian pathologist found nuclear abnormalities in normal-looking cells adjacent to and distant from sites of HGPIN and PC.
Bottom Line: Application of advanced analytic techniques to the study of tumor multifocality will move us closer to an understanding the genesis of prostate cancer.

« Back to Article List


(c) 2001 Seattle Prostate Institute -  All rights reserved.